Skip to main content

Animations

MJFF Publications

6741 - 6750 of 9145 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2020
  • 2018
  • 2026
  • 2017
  • 2013
  • 2023
  • 2026
  • 2025
  • Summary Details
    OPEN
    Title: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342
    Citation Count: 21
  • Parkinson's Progression Markers Initiative brain autopsy program
    2022
    Summary Details
    RESTRICTED
    Title: Parkinson's Progression Markers Initiative brain autopsy program
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.017
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.aaz9360
    Citation Count: 394
  • Summary Details
    OPEN
    Title: Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.008
    Citation Count: 113
  • Summary Details
    OPEN
    Title: Mitochondria as sources and targets of cellular signaling
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2026.01.008
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3
    Journal Name: neurogenetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1007/s10048-017-0514-8
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Cheek cell–derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.08.008
    Citation Count: 31
  • Summary Details
    OPEN
    Title: International Genetic Testing and Counseling Practices for Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29442
    Citation Count: 16
  • Summary Details
    OPEN
    Title: PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1007/s00259-025-07695-0
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Site-specific neuronal and motor effects of short-term intermittent burst deep brain stimulation in non-human primates
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.brs.2025.05.009
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.